U.S. Stem Cell, Inc. Quarterly Return On Equity in % from Q3 2012 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
U.S. Stem Cell, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2012 to Q4 2022.
  • U.S. Stem Cell, Inc. Return On Equity for the quarter ending December 31, 2022 was 20.4 %, a 25.5% decline year-over-year.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2022 was 20.4 %, a 25.5% decline from 2021.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2021 was 27.3 %, a 1.19% increase from 2020.
  • U.S. Stem Cell, Inc. annual Return On Equity for 2020 was 27 %, a 41.3% decline from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 20.4 -6.98 -25.5% Oct 1, 2022 Dec 31, 2022
Q3 2022 21.6 -5.94 -21.5% Jul 1, 2022 Sep 30, 2022
Q2 2022 23.2 -9.27 -28.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 27.5 -2.38 -7.96% Jan 1, 2022 Mar 31, 2022
Q4 2021 27.3 +0.32 +1.19% Oct 1, 2021 Dec 31, 2021
Q3 2021 27.6 -1.68 -5.74% Jul 1, 2021 Sep 30, 2021
Q2 2021 32.5 -3.4 -9.47% Apr 1, 2021 Jun 30, 2021
Q1 2021 29.9 -11.5 -27.8% Jan 1, 2021 Mar 31, 2021
Q4 2020 27 -19 -41.3% Oct 1, 2020 Dec 31, 2020
Q3 2020 29.3 -17.6 -37.5% Jul 1, 2020 Sep 30, 2020
Q2 2020 35.9 +3.99 +12.5% Apr 1, 2020 Jun 30, 2020
Q1 2020 41.4 +3 +7.81% Jan 1, 2020 Mar 31, 2020
Q4 2019 46 +14.4 +45.6% Oct 1, 2019 Dec 31, 2019
Q3 2019 46.9 +27 +136% Jul 1, 2019 Sep 30, 2019
Q2 2019 31.9 +3.87 +13.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 38.4 +22.1 +136% Jan 1, 2019 Mar 31, 2019
Q4 2018 31.6 -16 -33.6% Oct 1, 2018 Dec 31, 2018
Q3 2018 19.8 -26.5 -57.2% Jul 1, 2018 Sep 30, 2018
Q2 2018 28 -26.1 -48.2% Apr 1, 2018 Jun 30, 2018
Q1 2018 16.3 -36.1 -68.9% Jan 1, 2018 Mar 31, 2018
Q4 2017 47.6 +21.7 +84.2% Oct 1, 2017 Dec 31, 2017
Q3 2017 46.4 -0.9 -1.9% Jul 1, 2017 Sep 30, 2017
Q2 2017 54.1 +26.5 +95.6% Apr 1, 2017 Jun 30, 2017
Q1 2017 52.4 +40.9 +356% Jan 1, 2017 Mar 31, 2017
Q4 2016 25.8 +7.82 +43.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 47.3 +34.3 +264% Jul 1, 2016 Sep 30, 2016
Q2 2016 27.7 +2.36 +9.33% Apr 1, 2016 Jun 30, 2016
Q1 2016 11.5 -25.5 -68.9% Jan 1, 2016 Mar 31, 2016
Q4 2015 18 -2.35 -11.5% Oct 1, 2015 Dec 31, 2015
Q3 2015 13 -3.75 -22.4% Jul 1, 2015 Sep 30, 2015
Q2 2015 25.3 +12.1 +91.9% Apr 1, 2015 Jun 30, 2015
Q1 2015 37 +22.4 +154% Jan 1, 2015 Mar 31, 2015
Q4 2014 20.4 -2.41 -10.6% Oct 1, 2014 Dec 31, 2014
Q3 2014 16.8 -9.07 -35.1% Jul 1, 2014 Sep 30, 2014
Q2 2014 13.2 -12.3 -48.2% Apr 1, 2014 Jun 30, 2014
Q1 2014 14.6 -11.5 -44.1% Jan 1, 2014 Mar 31, 2014
Q4 2013 22.8 -7.45 -24.7% Oct 1, 2013 Dec 31, 2013
Q3 2013 25.8 -4.12 -13.8% Jul 1, 2013 Sep 30, 2013
Q2 2013 25.5 Apr 1, 2013 Jun 30, 2013
Q1 2013 26.1 Jan 1, 2013 Mar 31, 2013
Q4 2012 30.2 Oct 1, 2012 Dec 31, 2012
Q3 2012 29.9 Jul 1, 2012 Sep 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.